0001209191-12-058324.txt : 20121218 0001209191-12-058324.hdr.sgml : 20121218 20121218165412 ACCESSION NUMBER: 0001209191-12-058324 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121214 FILED AS OF DATE: 20121218 DATE AS OF CHANGE: 20121218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REYNOLDS FRANCIS CENTRAL INDEX KEY: 0001503383 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52089 FILM NUMBER: 121271919 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVIVO THERAPEUTICS HOLDINGS CORP. CENTRAL INDEX KEY: 0001292519 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400 EAST 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-863-5524 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400 EAST 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Design Source, Inc. DATE OF NAME CHANGE: 20040602 4 1 c30769_4x0.xml MAIN DOCUMENT DESCRIPTION X0306 4 2012-12-14 0001292519 INVIVO THERAPEUTICS HOLDINGS CORP. NVIV 0001503383 REYNOLDS FRANCIS C/O INVIVO THERAPEUTICS HOLDINGS CORP. ONE KENDALL SQUARE, SUITE B14402 CAMBRIDGE MA 02139 1 1 1 0 CEO, CFO COMMON STOCK 2012-12-14 4 S 0 750 1.65 D 14351410 D COMMON STOCK 2012-12-14 4 S 0 1000 1.73 D 14350410 D COMMON STOCK 2012-12-14 4 S 0 1500 1.66 D 14348910 D COMMON STOCK 2012-12-14 4 S 0 500 1.63 D 14348410 D COMMON STOCK 2012-12-14 4 S 0 500 1.6 D 14347910 D COMMON STOCK 2012-12-17 4 S 0 3250 1.6 D 14344660 D COMMON STOCK 2012-12-17 4 S 0 1000 1.63 D 14343660 D COMMON STOCK 2012-12-18 4 S 0 2000 1.61 D 14341660 D COMMON STOCK 2012-12-18 4 S 0 1000 1.65 D 14340660 D COMMON STOCK 2012-12-18 4 S 0 1250 1.63 D 14339410 D COMMON STOCK 13603 I By 401(k) Plan The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2012. /S/ ELIZABETH FRASER, AS ATTORNEY IN FACT 2012-12-18